Veracyte (VCYT)
(Delayed Data from NSDQ)
$31.94 USD
+0.32 (1.01%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $31.93 -0.01 (-0.03%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum B VGM
Price, Consensus and EPS Surprise
VCYT 31.94 +0.32(1.01%)
Will VCYT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VCYT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VCYT
Is It Apt to Hold Globus Medical Stock in Your Portfolio Now?
Should You Hold Labcorp (LH) Stock in Your Portfolio Now?
VCYT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y
Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy?
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
Other News for VCYT
Enhanced Financial Outlook for Veracyte Following Shift to Non-GAAP Reporting Metrics
Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle
Baron Discovery Fund Q2 2024 Shareholder Letter
First Week of October 18th Options Trading For Veracyte (VCYT)